We are live on ! Find out more
VVM

Versant Venture Management Portfolio holdings

AUM $141M
1-Year Est. Return 190.82%
This Fund
S&P 500
This Quarter Est. Return
-14.66%
1 Year Est. Return
+190.82%
3 Year Est. Return
+375.7%
5 Year Est. Return
+81.85%
10 Year Est. Return
+4,735.29%
AUM
$242M
AUM Growth
-$60.3M
Cap. Flow
-$5.3M
Cap. Flow %
-2.2%
Top 10 Hldgs %
99.81%
Holding
11
New
–
Increased
–
Reduced
2
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
GRTS
Gritstone bio, Inc. Common Stock
GRTS
+$4.05M
2
CRSP icon
CRISPR Therapeutics
CRSP
+$1.26M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRSP icon
1
CRISPR Therapeutics
CRSP
$4.68B
$55.8M 23.11%
498,558
-10,000
-2% -$1.26M
PASG icon
2
Passage Bio
PASG
$14.7M
$49.4M 20.45%
247,988
– –
GRTS
3
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$43.3M 17.91%
4,005,894
-444,744
-10% -$4.05M
ALGS icon
4
Aligos Therapeutics
ALGS
$26.3M
$36M 14.9%
92,815
– –
CRNX icon
5
Crinetics Pharmaceuticals
CRNX
$8.88B
$17.3M 7.15%
820,720
– –
AKRO
6
DELISTED
Akero Therapeutics
AKRO
$13.8M 5.72%
617,727
– –
ADVM
7
DELISTED
Adverum Biotechnologies
ADVM
$11M 4.55%
506,823
– –
APRE icon
8
Aprea Therapeutics
APRE
$7.6M
$6.44M 2.67%
62,983
– –
FLXN
9
DELISTED
Flexion Therapeutics, Inc.
FLXN
$6.1M 2.53%
1,000,000
– –
CBAY
10
DELISTED
Cymabay Therapeutics
CBAY
$1.99M 0.82%
543,753
– –
CLVS
11
DELISTED
Clovis Oncology, Inc.
CLVS
$454K 0.19%
101,855
– –

Similar funds

POIA
Pin Oak Investment Advisors Houston, Texas $141M AUM 20.83% 1-Year Est. Return
MAM
Maytree Asset Management Hong Kong $141M AUM 114% 1-Year Est. Return
TM
TFJ Management Somerville, Massachusetts $141M AUM 9.28% 1-Year Est. Return
IA
IF Advisors San Antonio, Texas $141M AUM
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
RB
Renasant Bank Tupelo, Mississippi $141M AUM 16.9% 1-Year Est. Return
YEPX
Yorktown Energy Partners XI New York $142M AUM 130.51% 1-Year Est. Return
CFGW
Chancellor Financial Group WB Wilkes-Barre, Pennsylvania $141M AUM 23.22% 1-Year Est. Return

Versant Venture Management's Q3 2021 Portfolio in Review

As of Q3 2021, Versant Venture Management held 11 positions worth $242M, down 20% from $302M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 0%. Versant Venture Management opened no new positions and made no exits, leaving the 11-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Versant Venture Management's biggest Q3 2021 reduction was Gritstone bio, Inc. Common Stock, cutting an estimated $4.05M.
  • Versant Venture Management's ten largest holdings make up 100% of its $242M portfolio in Q3 2021.
  • Versant Venture Management opened 0 new positions and closed 0 in Q3 2021.
  • Versant Venture Management's portfolio value fell 20% quarter-over-quarter to $242M.

Based on Versant Venture Management's 13F filing for Q3 2021, filed 12 Nov 2021.